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Abstract: Purpose
This study aimed to assess quality of life (QoL) in head and neck cancer (HNC)
survivors, and determine factors predictive of poor QoL in the first five years after the
end of treatment.
Methods
A cross-sectional survey, including the Quality of Life in Adult Cancer Survivors
(QLACS) measure, was sent to HNC survivors in three Scottish health regions, with
responses linked to routinely collected clinical data.  Independent sample t-tests,
ANOVAs, Pearson correlations and multiple hierarchical regressions were used to
explore associations between and to determine the contribution made by demographic,
lifestyle and clinical factors to predicting 'generic' and 'cancer-specific' quality of life.
Results
280 patients (65%) returned questionnaires.  After adjustment, multivariate analysis
showed that younger age, lower socio-economic status, unemployment and self-
reported comorbidity independently contributed to poorer generic and cancer-specific
quality of life. In addition to these factors, having had a feeding tube or a diagnosis of
oral cavity cancer were independently predictive of poorer cancer-specific quality of
life.
Conclusions
Socio-economic factors and co-morbidity are important predictors of QoL in HNC
survivors.  These factors and the detrimental long-term effects of feeding tubes need
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Abstract  
Purpose 
This study aimed to assess quality of life (QoL) in head and neck cancer (HNC) survivors, and 
determine factors predictive of poor QoL in the first five years after the end of treatment.   
Methods 
A cross-sectional survey, including the Quality of Life in Adult Cancer Survivors (QLACS) 
measure, was sent to HNC survivors in three Scottish health regions, with responses linked 
to routinely collected clinical data.  Independent sample t-tests, ANOVAs, Pearson 
correlations and multiple hierarchical regressions were used to explore associations 
between and to determine the contribution made by demographic, lifestyle and clinical 
factors to predicting ‘generic’ and ‘cancer-specific’ quality of life.   
Results  
280 patients (65%) returned questionnaires.  After adjustment, multivariate analysis showed 
that younger age, lower socio-economic status, unemployment and self-reported 
comorbidity independently contributed to poorer generic and cancer-specific quality of life. 
In addition to these factors, having had a feeding tube or a diagnosis of oral cavity cancer 
were independently predictive of poorer cancer-specific quality of life.     
Conclusions  
Socio-economic factors and co-morbidity are important predictors of QoL in HNC survivors.  
These factors and the detrimental long-term effects of feeding tubes need further attention 
in research and practice.  
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Introduction 
 
Head and neck cancer (HNC) is the sixth most common cancer worldwide and its incidence is 
rising.  In the UK alone a 51% increase in male oral and oropharyngeal squamous cell 
carcinoma is mainly attributed to the rise in Human Papillomavirus (HPV) related cancers 
[1].  In Scotland, incidence rates are particularly high [2].   Low socio-economic status (SES), 
smoking, alcohol abuse, a lack of social support, and poor psychological health are all 
strongly associated with increased incidence and poor prognosis [3, 4].  Patients with HNC 
therefore represent a vulnerable group.   
In 2008, more than 1.5 million people with HNC worldwide were still alive up to five years 
after diagnosis [5].  In the UK, around 50% of people with oral cancer and 60% of people 
with laryngeal cancer now survive for five years or more [6] .   Patients with HPV-related 
cancers respond more favourably to treatment, and the number living with HNC is likely to 
increase significantly over the next 10-20 years [7].  The needs and concerns of survivors are 
therefore of increasing relevance to the provision of long-term support. 
The physical and psychosocial impact of HNC is considerable, as the consequences of 
treatment can include severe pain, fatigue, anxiety, depression, dry mouth, speech, 
swallowing and body image problems, among many others.   Quality of life is fundamentally 
important, as patients experience significant changes in the acute phase of treatment, and 
many suffer longer term functional difficulties [8-10]. The negative psychosocial 
consequences of HNC can be equally enduring [11]. Quality of life has also been shown to 
predict survival in this patient group [12]. 
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The factors which influence poor quality of life (QoL) outcomes in people with HNC become 
increasingly important as healthcare systems consider how best to utilise finite resources in 
the follow-up care of a growing number of survivors.  The concept of risk stratification has 
attracted much attention in the context of survivorship care, as it provides a means of 
quantifying the probability of adverse outcomes in a patient group, and suggests which 
patients are likely to be at particular risk of poor outcomes, therefore enabling health care 
professionals to intervene appropriately [13].  Some predictors of poor QoL have been 
identified including feeding tubes [14] pre-treatment QoL, comorbidity and stage [15].  
However, most studies have used instruments designed to evaluate clinical trial outcomes, 
rather than more holistic measures of long-term quality of life.   
The Quality of Life in Adult Cancer Survivors (QLACS) scale was developed specifically to 
elicit the issues relevant to people living with cancer in the longer term, including those with 
HNC [16, 17].   The QLACS conceptualization of cancer-related quality of life comprises two 
key components: the ability to perform everyday activities reflecting physical, psychological, 
and social well-being; and patient satisfaction with levels of functioning and control of their 
cancer [18]. The QLACS domains were considered highly relevant to HNC survivors as they 
included topics such as social avoidance, sexual concerns, financial problems, appearance 
and fear of recurrence as well as standard items such as pain and fatigue. 
This cross-sectional study aimed to elicit the quality of life, concerns, unmet needs and 
distress associated with living with and beyond a diagnosis of HNC.  This paper reports the 
QoL of HNC survivors who had completed treatment up to five years previously, and 
illustrates which clinical and socio-demographic factors were predictive of poor quality of 
life.  Data on unmet needs and concerns is reported elsewhere [19]. 
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Materials and Methods 
Data collection 
 
A questionnaire booklet with reply envelope was posted to HNC survivors on the databases 
of Clinical Nurse Specialists (CNS) in three Scottish health boards.  The booklet contained the 
QLACS [17], the Distress Thermometer (DT)[20], Patient Concerns Inventory (PCI)[21] and an 
unmet needs inventory adapted from the PCI. Questions were also asked about age, gender, 
nationality, relationship status, living arrangements, current smoking and drinking habits, 
treatment type, feeding tube use, employment status, and co-morbidities.   
Participants over 18 were eligible if they had completed treatment between three months 
and five years before the survey was mailed.  Survivors were excluded by the CNS if they 
were receiving palliative care, had a prognosis of < six months, did not speak English, or 
were considered likely to find the survey distressing. 
 
Anonymised questionnaires, identified only by study number, were returned to the 
researchers.  CNS’ sent reminder letters to potential participants who had not returned their 
questionnaire within four weeks. Data collection took place between May and December 
2011. Ethical approval was granted by the Tayside Committee on Medical Ethics. 
Study numbers and corresponding unique 10-digit community health index (CHI) numbers 
were submitted by CNS’ to the Health Informatics Centre (HIC -
http://www.dundee.ac.uk/HIC), which holds routine clinical datasets, including cancer 
registry hospital admission records, on every cancer patient registered with a General 
Practitioner (GP) in two of the participating health board regions.  International 
Classification of Diagnosis (ICD 10) codes for diagnosis, UICC stage, date of diagnosis, and 
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Scottish Index of Multiple Deprivation (SIMD) indices based on home postcode were linked 
to questionnaire data for all participants.  Because HIC did not hold routine data for our 
third participating region, the required clinical and socio-demographic information was 
transferred from the CNS to HIC using a secure mechanism. Time from diagnosis was 
calculated from cancer registry or CNS records to the date of survey completion.  The 
extended dataset was anonymised and made available to the research team via a secure 
data safe haven.  
The QLACS scale consists of 47 Likert scale items. Patients evaluate statements with 
reference to the preceding four weeks, indicating how frequently (from “never” to “always”) 
the statements have applied to them. Questions can be summed to produce domain scores 
for generic QoL (including subscales for negative feelings, positive feelings, cognitive 
problems, sexual problems, physical pain, fatigue, and social avoidance), cancer-related QoL 
(including subscales for appearance concerns, financial problems, distress over recurrence, 
and family-related distress), and benefits of cancer.  
 
Summary domain scores range from 4 to 28, with higher scores indicating negative 
outcomes (low QoL) for all domains except for the “positive feelings” and “benefits” 
domains (for which higher scores indicate positive outcomes (high QoL).  Evaluation of the 
test-retest reliability, internal consistency, validity, and sensitivity to change of QLACS has 
shown that its overall reliability is high [16, 17].   
Statistical analysis 
 
Differences between responders and non-responders were tested using chi-squared tests 
for categorical variables. Data were described as number of subjects (percentages) for 
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categorical variables and mean (standard deviation) for continuous variables or where the 
distribution was skewed, median and interquartile range (IQR). Blank responses in the 
QLACS questionnaire were handled using case-mean substitution [22] and subscales and 
domains were scored using published procedures [17]. Independent sample t-tests and 
ANOVAs were run to explore the associations between domain scores for generic and 
cancer-specific quality of life and (i) demographic factors – gender, age, SIMD and living 
arrangements; (ii) lifestyle factors – smoking status, alcohol status and employment status; 
(iii) clinical factors – diagnosis (larynx, oropharynx, oral cavity or other), length of time since 
diagnosis, type of treatment (surgery alone or treatment including radiotherapy or 
chemotherapy) and whether or not feeding tube had ever been fitted. Pearson correlations 
were run to explore the association between domain scores for generic and cancer-specific 
QoL and number of comorbidities (self-reported). Hierarchical multiple regressions were 
conducted to test the contribution of the demographic, lifestyle and clinical factors to 
predicting (i) cancer-specific QoL (ii) generic QoL. Dummy variables were created for 
Diagnosis – oropharynx, oral cavity and other site, with the larynx dummy variable as the 
reference.  UICC stage was not entered, because of missing data.  Where the distribution 
was skewed, differences in continuous variables were examined using a Mann-Whitney test 
or a Kruskal Wallis test.  All statistical analyses were performed using IBM SPSS Version 23. 
Results 
 
488 questionnaires were distributed and 319 (65%) returned. The socio-demographic 
characteristics of responders versus non-responders were compared, with no differences in 
response by gender, age, or time since diagnosis. However, the response rate was 
significantly better for patients from the highest SES group (SIMD 5) (83%) compared to 53% 
from the lowest (SIMD 1); p<0.0001. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Of the 319 questionnaires returned, 39 were from people who had completed treatment 
more than five years previously and so were outside the time period defined for the cohort. 
There were some missing data in the remaining 280, but 264 had completed enough items 
to be scored on the cancer-specific summary score and 259 on the generic summary score. 
The main demographic, lifestyle and clinical characteristics are shown in Table 1. 
Participants were aged between 27 and 91 years old with a mean age of 64.28 years (SD 
11.27). The time from diagnosis to survey participation ranged from three to 71 months, 
with a median of three years (35.72 months). Most respondents were male (73%), married 
(63%) with approximately one quarter who lived alone. 112 (41%) were from the lowest SES 
populations (SIMD 1 and 2), although respondents were fairly evenly distributed across all 
five rankings. Cancers of the oral cavity or larynx affected one third each of the study 
population. The remaining third of participants had a diagnosis of oropharyngeal cancer 
(20%) or another less common type of HNC, for instance salivary gland tumour or cancer of 
unknown primary (13%). Cancer stage was missing or unknown for 25% of the sample. 
Insert Table 1 
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Quality of life (QoL) scores 
QLACS scores for generic QoL ranged from 26 to 181, with a median score of 70 (IQR 39). 
Cancer-specific QoL scores ranged from 15 to 94, with a median score of 34 (IQR 25). QLACS 
scores for generic and cancer-specific QoL were positively skewed, illustrating that the 
majority of survivors deemed their quality of life to be good, although a tail of poorly scoring 
participants clearly existed. Median summary scores for individual subscales varied, with the 
lowest (best) median score for ‘financial problems’ and highest (worst) for ‘distress-
recurrence’ and ‘fatigue’ (Table 2). 
Insert Table 2 
Predictors of cancer-specific quality of life 
 
There were significant differences in mean cancer-specific QoL scores by gender (t(260)=-
2.635, p=0.009), age (F(4,259)=6.047, p<0.001), SIMD (F(4,259)=4.067, p=0.003), smoking 
status (t(65)=-3.052, p=0.003), employment status (F(2,260)=11.715, p<0.001), type of 
diagnosis (F(3,259)=3.892, p=0.010), and whether or not a feeding tube had been fitted 
(t(258.99)=-4.636, p<0.001) (Table 3). Post-hoc analysis revealed that participants who were 
retired had significantly higher cancer-specific QoL scores than participants who were in 
employment or out of work (Table 3). Patients with oral cavity cancer had significantly 
worse cancer-specific QoL scores than patients with cancer of the larynx (Table 3). There 
was a significant correlation between cancer related QoL and number of comorbidities 
(r=0.232, p<0.001).  Hierarchical multiple regression analysis revealed that demographic, 
lifestyle and clinical factors predicted 33.7% of the variance in cancer-specific QoL score 
(F(14,226) = 8.206, p<0.001). Being younger, having a lower socio-economic status, being 
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out of work, having a greater number of comorbidities, having ever had a feeding tube fitted 
and having a diagnosis of oral cavity cancer all independently contributed to poorer cancer-
specific QoL based on the score (Table 4). 
Insert Tables 3 and 4 
Predictors of generic quality of life 
 
There were significant differences in mean generic QoL scores by gender (t(255)=-2.372, 
p=0.018, SIMD (F(4,254)=3.531, p=0.008), smoking status (t(56.48)=-2.148, p=0.036), alcohol 
status (t(257)=2.395, p=0.017), employment status (F(2,256)=8.099, p<0.001), and whether 
or not a feeding tube had ever been fitted (t(253.96)=-2.311, p=0.022. There was a 
significant correlation between generic QoL and number of comorbidities (r=0.413, 
p<0.001). Hierarchical multiple regression analysis revealed that demographic, lifestyle and 
clinical factors predicted 32.8% of the variance in generic QoL score (F(14,224) = 7.827, 
p<0.001). Being younger, having a lower socio-economic status, being out of work, and 
having a greater number of comorbidities independently contributed to poorer generic QoL 
scores (Table 4). 
Sub-scale analysis 
 
Given that the significant effects of ever having had a feeding tube fitted and type of 
diagnosis appeared to be on the cancer-specific QoL score rather than the generic score, we 
investigated the relationship between feeding tube and individual sub-scales which 
contribute to the cancer-specific summary score (appearance concerns, financial problems, 
distress over recurrence, family-related distress and benefits of cancer) to see whether the 
effects might be associated with particular sub-scales. Median scores were significantly 
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higher (worse) for participants who had ever had a feeding tube fitted in the appearance 
concerns, financial problems and family-related distress sub-scales. Median scores differed 
significantly by type of diagnosis in the appearance and distress over recurrence sub-scales, 
with oral cavity cancer scoring highest (worse QoL) in both sub-scales (Table 5). 
Insert Table 5 
In the regression analysis for both generic and cancer-specific QoL, lower SES was found to 
be a significant predictor of having worse QoL scores. In order to investigate whether there 
was a relationship between SES and particular sub-scales, we explored the median scores 
and inter-quartile ranges for each sub-scale (Table 7). Scores were consistently higher 
(worse) in the most deprived groups across all sub-scales, however there was only a 
statistically significant difference between SIMD groups in the physical pain and fatigue sub-
scales.  
Insert Table 6 
Discussion 
 
This cross-sectional study investigated the quality of life of survivors of head and neck 
cancer in the first five years after the end of treatment.  Our first key finding is that, after 
controlling for clinical and socio-demographic factors, low socio-economic status, being out 
of work, having a greater number of comorbidities and being younger are independent 
predictors of reduced cancer-specific and generic quality of life in HNC survivors.  The 
second key finding of our study was that having a diagnosis of oral cavity cancer and ever 
having had a feeding tube fitted were also independent predictors of reduced cancer-
specific quality of life.   
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Unadjusted analyses suggest that differences in individual QoL domains, particularly those 
that are specific to cancer, may exist between groups, with survivors of oral cancer having 
poorer scores than those with oropharyngeal or laryngeal cancers.  Smoking, age, gender, 
unemployment, low socio-economic status and having a feeding tube appear to have a 
detrimental effect on cancer-specific and generic QoL, whereas drinking some alcohol 
appeared to improve the latter.   
Patients with head and neck cancer are assumed to be difficult to reach,  however, we 
achieved a response rate similar to that of the English patient experience survey, which 
gathered postal data from survivors of other more common cancers [23]. We also found 
that people of lower SES were significantly less likely to respond, but in our study, there was 
no difference in the age of responders versus non-responders.   Our QLACS scores were 
slightly lower (better) than the sample in Avis et al’s (18) study, but they are not directly 
comparable because the authors reported mean rather than median scores.      
There is a well-established link between survival and low socio-economic status, although 
recent studies have found that neighbourhood deprivation may not be an independent 
predictor across all HNC types [24, 25].  This could suggest that the measure of deprivation 
is acting as a confounder for other unmeasured factors.  Our research confirms the results 
of several studies establishing an association between employment, income, deprivation, 
education or other socioeconomic factors and QoL in this patient group [26, 27].  An under-
powered Turkish study [26] found that after controlling for other factors, only “social 
security status” remained a significant predictor of a mental health QoL score. Our study 
may therefore be the first with sufficient power to establish that low SES is associated with 
reduced quality of life in HNC survivors.  We also found that common symptoms including 
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pain and fatigue appear to be significantly worse in people from poorer socio-economic 
backgrounds, suggesting that careful symptom assessment and management may be even 
more important in this group. 
There are a range of complex reasons why low SES may adversely affect outcomes in 
survivors of cancer [28] and these apply to head and neck as much as any other cancer.  For 
example, a large survey found a significant link between deprivation, psychological distress 
and, to a lesser extent, social difficulties[29].  People who are socially deprived are more 
likely to suffer from a number of co-morbid conditions [30] and make greater use of health 
services than people in higher socio-economic groups [31].  A recent review [32] shows that 
comorbidity is associated with poorer outcomes (including quality of life) in people with 
HNC, and suggests that comorbidity data should be routinely collected by clinical teams.  
Although this is the ideal, our own findings support the potential for self-report of co-
morbid conditions [33].     
Other studies have found that the presence of a gastrostomy tube at one-year post 
treatment was associated with poorer quality of life [14, 15], but we found an independent 
effect for having a feeding tube at any time during the follow-up period assessed.  Most 
patients treated with chemo-radiation require a feeding tube during or after treatment and 
early nutritional intervention is widely regarded as important [34].  However, the choice of 
enteral route and the timing of insertion are controversial.  A recent systematic review [35] 
concluded that gastrostomy tubes, in particular, may inhibit swallowing function. Our data 
add further evidence that the long-term consequences of feeding tubes should not be 
under-estimated, and that there are particularly detrimental effects on appearance, family 
and finances, although the direction of this relationship is unclear.  We acknowledge that 
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maintaining adequate nutrition in this patient group is challenging, and further research is 
required to determine the long-term impact of feeding tubes and to specify the pathways by 
which a feeding tube might affect quality of life. 
Whereas smoking was associated with worse QoL in unadjusted analysis (as in other studies 
e.g. [36]), drinking some alcohol appeared to be protective.  Social drinking has previously 
been associated with improved quality of life although problem drinkers have the worst 
outcomes of all [37, 38].  We did not detect a difference between light/moderate and heavy 
drinkers but this may reflect inaccurate self-reporting by our participants.    
Our data suggest that being unemployed adversely affects QoL.  Patients with HNC appear 
to have more problems returning to work than patients with other cancers [39, 40].  Barriers 
include anxiety, difficulties with social interaction and social eating, oral and dental 
problems, although in a recent Dutch study, 83% still returned to work [41].  Working after 
cancer has a range of benefits including financial security, confidence and self-identity, but 
qualitative studies illustrate the numerous challenges and changes that people experience 
in the workplace and there is a real need to develop interventions that are tailored to 
individuals’ work-related goals [42].    
This is one of the few cross-sectional studies in HNC to use a measure designed to assess 
quality of life beyond the acute stages of diagnosis and treatment, and to link patient-
reported outcomes to reliable routinely collected clinical and socio-economic data.  There 
are, however, a number of limitations to this study.  Firstly, cross-sectional studies only 
provide a snapshot of QoL, cannot assess change over time and demonstrate associations 
not causality.  Their results are inevitably biased towards those patients with the most 
favourable survival as they exclude people who have already died (24).  Secondly, the 
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representativeness of the survey cannot be assumed.  Although questionnaires were sent to 
as many patients as the CNS’ could identify from their databases, which ensured a clinically 
heterogeneous sample of patients with different cancers and time from diagnosis, it is likely 
that some potential participants were not sent questionnaires.  It is also possible that the 
quality of life of responders was different to that of non-responders.  Some patients 
commented that scoring QoL based on the ‘last four weeks’ (as per the wording of the 
questionnaire) was difficult, as issues were not necessarily relevant to the last month but 
had been relevant at other times.    Finally, there is a risk that multiple comparisons could 
generate some false positive results.  Further research is required to prospectively assess 
relationships between the variables we have identified. 
There are a number of clinical implications arising from this study.  Our results suggest that 
factors associated with poor QoL among survivors can be identified and used to direct 
support to those in most need.  Data on SES may not be routinely available to clinicians, and 
sensitivity is required if people from lower socio-economic groups are to be targeted for 
additional attention.  However, our study suggests that it is important to consider the 
‘double whammy’ of head and neck cancer treatment in addition to the material, 
psychosocial, environmental, behavioural, intellectual, cultural and physical effects of low 
SES, and that individualised holistic assessment is particularly important in this patient 
group.  Clinicians providing follow-up care should also be aware that feeding tubes may be 
associated with long-term consequences on quality of life that are not necessarily directly 
linked to problems with eating and swallowing. 
Conclusion  
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Many head and neck cancer survivors experience poor quality of life in the first five years 
after treatment.  This cross-sectional study shows that younger age, unemployment, low 
socio-economic status, increased co-morbidity, and having a feeding tube are important 
predictors of poor quality of life in this patient group.  These factors must be considered 
more carefully in in research and practice, with greater attention paid to the needs of 
survivors who are most at risk.  
Disclosures: None
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Table 1 Demographic, lifestyle and clinical characteristics of the respondents (n=280) 
Patient Characteristics N % 
Age   
<45 years 
45 – 54 years 
55 – 64 years 
65 – 74 years 
75 years and over 
Missing 
13 
35 
83 
94 
48 
7 
5 
13 
30 
34 
17 
2 
Gender   
Male 
Female 
204 
76 
73 
27 
Scottish Index of Multiple 
Deprivation (SIMD) 
  
Most deprived (SIMD 1) 
2 
3 
4  
Least deprived (SIMD 5) 
49 
63 
51 
71 
46 
18 
23 
18 
26 
16 
Marital status   
Married 
Single 
Not living alone 
Divorced/separated 
Widowed  
missing 
173 
22 
19 
28 
31 
7 
63 
8 
7 
10 
11 
3 
Living Alone   
Yes 
No  
Missing 
66 
204 
10 
23 
73 
4 
Employment at Time of Diagnosis   
Employed 
Out of work 
Retired 
Missing 
125 
38 
109 
8 
45 
14 
39 
3 
Employed Currently   
Yes 
No 
Retired 
Missing 
84 
76 
112 
8 
30 
27 
40 
3 
Current Smoker   
Yes 
No 
Missing 
50 
223 
7 
18 
80 
2 
Current Alcohol Drinker   
Yes 173* 62 
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 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
No 
Missing 
100 
7 
36 
2 
Diagnosis   
Larynx 
Oropharynx 
Oral cavity 
Other 
Missing data 
92 
57 
94 
36 
1 
33 
20 
34 
13 
<1 
Stage (UICC)   
I 
II 
III 
IV 
Unknown primary 
Missing data 
64 
43 
38 
66 
3 
66 
23 
15 
14 
24 
1 
24 
Time since diagnosis   
Up to 1 year 
1-2 years 
2-3 years 
3-4 years 
>4 years 
25 
62 
53 
70 
70 
9 
22 
19 
25 
25 
Treatment (self-report)   
Surgery only (includes 2 laser) 
Radiotherapy 
Surgery and radiotherapy 
Surgery and chemotherapy 
Chemoradiotherapy 
All (surgery, RT, chemo) 
Missing data 
73 
48 
32 
2 
50 
64 
11 
26 
17 
11 
1 
18 
23 
 
Feeding-tube History   
Ever fitted 
Never fitted 
Missing data 
150 
120 
10 
56 
44 
Duration of feed-tube required   
Up to 3 months 
3-6 months 
7-12 months 
13 - 18 months 
Still in place 
Missing data  
81 
32 
14 
1 
17 
5 
54 
21 
9 
<1 
11 
 
Total no. listed co-morbid 
conditions 
  
None 
1 
2 
3 
4 
99 
84 
35 
21 
20 
35 
30 
13 
8 
7 
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5 or more 9 3 
Co-morbid conditions (self-report)   
Diabetes 
Heart problems 
Lung problems 
Stroke 
Arthritis 
Other cancer 
Heartburn 
Other condition 
33 
47 
28 
12 
51 
27 
56 
87 
11 
15 
9 
4 
17 
9 
18 
28 
* of whom 80 described themselves as moderate and 7 as heavy drinkers 
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 Table 2 Domain and subscale median scores (n-280) 
 Median Inter-quartile range 
Generic Quality of Life# 70 39 
Negative feelings# 
Positive feelings* 
Cognitive problems# 
Sexual problems# 
Physical pain# 
Fatigue# 
Social avoidance# 
10 
22 
9 
10 
8 
13 
8 
7 
10 
6 
11 
7 
9 
8 
Cancer-Specific Quality of 
Life# 
34 25 
Appearance concerns# 
Financial problems# 
Distress over recurrence# 
Family-related distress# 
Benefits of cancer* 
6 
5 
12 
7 
18 
7 
6 
9 
8 
10 
#higher scores indicate poorer quality of life 
*higher scores indicate better quality of life 
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Table 3 Demographic, lifestyle and clinical factors and their association with cancer-specific 
and generic quality of life scores. 
 Mean Cancer-Specific 
QoL Score# (sd) 
P Mean Generic 
QoL Score# (sd) 
p 
Gender 
- Male 
- Female 
 
36.21 (16.80) 
42.62 (18.97) 
 
0.009 
 
73.32 (30.24) 
83.81 (33.52) 
 
0.018 
Age 
- <45 years 
- 45 – 54 years 
- 55 – 64 years 
- 65 – 74 years 
- ≥75 years  
 
43.81 (21.07) 
46.84 (19.98) 
40.54 (18.68) 
34.07 (13.87) 
31.46 (15.51) 
 
<0.001 
 
83.77 (31.19) 
82.94 (38.27) 
79.79 (35.59) 
69.98 (26.83) 
73.32 (22.16) 
 
0.118 
SIMD 
- 1 (most deprived) 
- 2 
- 3 
- 4 
- 5 (least deprived) 
 
44.03 (22.16) 
41.88 (18.57) 
34.65 (13.52) 
36.28 (16.54) 
31.93 (13.91) 
 
0.003 
 
87.47 (39.39) 
81.86 (31.60) 
73.22 (29.93) 
72.13 (28.98) 
65.93 (22.56) 
 
0.008 
Living arrangements 
- Another 
person lives in 
household 
- Lives alone 
 
37.77 (17.28) 
 
 
37.63 (17.99) 
 
0.954 
 
75.86 (30.83) 
 
 
76.50 (33.71) 
 
0.895 
Smoking status 
- Non-smoker 
- Smoker 
 
36.03 (16.47) 
45.40 (20.22) 
 
0.003 
 
73.59 (28.52) 
86.98 (40.58) 
 
0.036 
Alcohol status 
- Non-drinker 
- Drinker 
 
39.70 (19.02) 
36.75 (16.71) 
 
0.211 
 
82.20 (33.26) 
72.55 (29.85) 
 
0.017 
Employment status 
- Out of work 
- Employed 
- Retired 
 
44.48 (20.26) 
38.76 (16.75) 
32.16 (14.20) 
 
<0.001 
 
87.97 (37.76) 
70.61 (26.43) 
71.61 (27.66) 
 
<0.001 
Diagnosis 
- Larynx 
- Oropharynx 
- Oral cavity 
- Other 
 
33.69 (17.25) 
36.85 (14.65) 
42.56 (17.66) 
38.01 (20.19) 
 
0.010 
 
73.14 (29.64) 
73.17 (29.73) 
80.84 (32.72) 
76.88 (34.13) 
 
0.357 
Length of time since 
diagnosis 
- Up to 1 year 
- 1-2 years 
 
 
35.10 (16.08) 
36.77 (14.46) 
 
 
0.795 
 
 
73.82 (30.39) 
73.61 (32.39) 
 
 
0.980 
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33 
34 
35 
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39 
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41 
42 
43 
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48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
- 2-3 years 
- 3-4 years 
- >4 years 
39.95 (19.51) 
38.47 (17.26) 
36.68 (18.94) 
75.88 (27.88) 
76.29 (27.12) 
77.04 (37.20) 
Type of treatment 
- Surgery alone 
- Other 
treatment~ 
 
38.26 (18.08) 
 
37.56 (17.29) 
 
0.773 
 
79.64 (33.82) 
 
74.47 (30.43) 
 
0.243 
Feeding tube fitted 
- Never 
- Ever 
 
32.39 (14.73) 
41.93 (18.53) 
 
<0.001 
 
71.16 (25.71) 
79.92 (35.00) 
 
0.022 
~ Treatment including chemotherapy or radiotherapy  
# higher scores indicate poorer quality of life 
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Table 4 Summary of hierarchical regression analysis for variables predicting cancer-specific and generic quality of life 
 Cancer-specific quality of life  Generic quality of life 
 Model 1 Model 2 Model 3  Model 1 Model 2 Model 3 
 (Demographics) (Demographics 
+ Lifestyle) 
(Demographics, 
Lifestyle 
+Clinical) 
 (Demographics) (Demographics 
+ Lifestyle) 
(Demographics, 
Lifestyle 
+Clinical) 
Variable β β Β  β β Β 
Female 0.148* 0.131* 0.090  0.142* 0.106 0.098 
Age -0.280** -0.264** -0.292**  -0.158* -0.153* -0.213** 
Living alone 0.030 0.031 0.000  0.009 0.017 0.003 
SIMD -0.213** -0.152* -0.168**  -0.221** -0.150* -0.145* 
Current smoker  0.114 0.095   0.128* 0.074 
Current non-drinker  -0.068 -0.028   -0.135* -0.074 
Not employed or retired  -0.224** -0.144*   -0.227** -0.150* 
Time since diagnosis   0.030    -0.016 
Number of comorbidities   0.243**    0.389** 
Treatment other than surgery 
alone 
  0.090    -0.003 
Feeding tube ever fitted   0.204**    0.112 
Oropharynx diagnosis   -0.047    -0.039 
Oral cavity diagnosis   0.172*    0.034 
Other site diagnosis   0.061    0.030 
ΔR2 0.147** 0.068** 0.122**  0.098** 0.083** 0.147** 
Total R2 0.147** 0.215** 0.337**  0.098** 0.181** 0.328** 
*p<0.05 
**p<0.01 
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Table 5 Cancer-specific quality of life subscale median scores for feeding tube and type of diagnosis 
 Appearance 
concerns 
p Financial 
problems 
p Distress over 
recurrence 
p Family related 
distress 
p Benefits of 
cancer 
p 
Feeding Tube  
Median (IQR) 
Ever Fitted 
Never Fitted 
 
 
9 (11) 
4 (3) 
 
 
<0.001 
 
 
7.5 (8) 
4 (4) 
 
 
<0.001 
 
 
12 (10) 
11 (9) 
 
 
0.069 
 
 
7.33 (9) 
5.33 (8) 
 
 
0.044 
 
 
18 (10) 
16.5 (10) 
 
 
0.524 
Type of Diagnosis 
Median (IQR) 
Larynx 
Oropharynx 
Oral Cavity 
Other 
 
 
4 (5) 
6 (6) 
8 (9) 
5 (10) 
 
 
0.009 
 
 
4 (5) 
8 (9) 
6 (7) 
4 (4) 
 
 
0.073 
 
 
10 (9) 
11 (8) 
15 (10) 
12 (11) 
 
 
0.001 
 
 
5.33 (7) 
7.33 (8) 
8.66 (9) 
6 (9) 
 
 
0.105 
 
 
18 (10) 
18 (13) 
18 (8) 
16 (12) 
 
 
0.631 
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 Table 6 QLACS sub-scale median scores by SIMD category 
 SIMD 1 SIMD 2 SIMD 3 SIMD 4 SIMD 5 p 
Generic Quality of Life Median (IQR) Median (IQR) Median (IQR) Median (IQR) Median (IQR)  
Negative feelings# 
Positive feelings* 
Cognitive problems# 
Sexual problems# 
Physical pain# 
Fatigue# 
Social avoidance# 
11 (9) 
22 (13) 
11 (12) 
10 (9) 
10 (9) 
16.5 (10) 
10 (11) 
10 (6) 
21 (9) 
9 (5) 
14 (12) 
9 (9) 
12 (9) 
8 (11) 
9 (6) 
22.5 (10) 
9 (6) 
10.5 (12) 
8 (80) 
12 (8) 
7.5 (9) 
9 (5) 
22 (9) 
8 (7) 
10 (11) 
7 (6) 
12 (8) 
7 (7) 
9 (6) 
22 (7) 
7 (6) 
9 (9) 
6 (5) 
12 (6) 
7 (7) 
0.146 
0.370 
0.085 
0.125 
0.004 
0.046 
0.227 
Cancer-Specific Quality of 
Life 
      
Appearance concerns# 
Financial problems# 
Distress over recurrence# 
Family-related distress# 
Benefits of cancer* 
7 (11) 
7 (10) 
15.5 (15) 
7.16 (9) 
17 (10) 
8 (11) 
6 (7) 
14 (11) 
9 (8) 
18 (10) 
6.5 (7) 
4 (4) 
12 (7) 
5.5 (8) 
18 (10) 
5 (6) 
6 (7) 
11 (9) 
6.66 (9) 
18 (11) 
5 (5) 
4 (5) 
10 (6) 
5.33 (6) 
19 (10) 
0.173 
0.067 
0.067 
0.108 
0.477 
*higher scores indicate better quality of life 
#higher scores indicate poorer quality of life 
NB SIMD 1 = most deprived; SIMD 5 = least deprived 
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Table 1 Demographic, lifestyle and clinical characteristics of the respondents (n=280) 
Patient Characteristics N % 
Age   
<45 years 
45 – 54 years 
55 – 64 years 
65 – 74 years 
75 years and over 
Missing 
13 
35 
83 
94 
48 
7 
5 
13 
30 
34 
17 
2 
Gender   
Male 
Female 
204 
76 
73 
27 
Scottish Index of Multiple 
Deprivation (SIMD) 
  
Most deprived (SIMD 1) 
2 
3 
4  
Least deprived (SIMD 5) 
49 
63 
51 
71 
46 
18 
23 
18 
26 
16 
Marital status   
Married 
Single 
Not living alone 
Divorced/separated 
Widowed  
missing 
173 
22 
19 
28 
31 
7 
63 
8 
7 
10 
11 
3 
Living Alone   
Yes 
No  
Missing 
66 
204 
10 
23 
73 
4 
Employment at Time of Diagnosis   
Employed 
Out of work 
Retired 
Missing 
125 
38 
109 
8 
45 
14 
39 
3 
Employed Currently   
Yes 
No 
Retired 
Missing 
84 
76 
112 
8 
30 
27 
40 
3 
Current Smoker   
Yes 
No 
Missing 
50 
223 
7 
18 
80 
2 
Current Alcohol Drinker   
Yes 173* 62 
Table
No 
Missing 
100 
7 
36 
2 
Diagnosis   
Larynx 
Oropharynx 
Oral cavity 
Other 
Missing data 
92 
57 
94 
36 
1 
33 
20 
34 
13 
<1 
Stage (UICC)   
I 
II 
III 
IV 
Unknown primary 
Missing data 
64 
43 
38 
66 
3 
66 
23 
15 
14 
24 
1 
24 
Time since diagnosis   
Up to 1 year 
1-2 years 
2-3 years 
3-4 years 
>4 years 
25 
62 
53 
70 
70 
9 
22 
19 
25 
25 
Treatment (self-report)   
Surgery only (includes 2 laser) 
Radiotherapy 
Surgery and radiotherapy 
Surgery and chemotherapy 
Chemoradiotherapy 
All (surgery, RT, chemo) 
Missing data 
73 
48 
32 
2 
50 
64 
11 
26 
17 
11 
1 
18 
23 
 
Feeding-tube History   
Ever fitted 
Never fitted 
Missing data 
150 
120 
10 
56 
44 
Duration of feed-tube required   
Up to 3 months 
3-6 months 
7-12 months 
13 - 18 months 
Still in place 
Missing data  
81 
32 
14 
1 
17 
5 
54 
21 
9 
<1 
11 
 
Total no. listed co-morbid 
conditions 
  
None 
1 
2 
3 
4 
99 
84 
35 
21 
20 
35 
30 
13 
8 
7 
5 or more 9 3 
Co-morbid conditions (self-report)   
Diabetes 
Heart problems 
Lung problems 
Stroke 
Arthritis 
Other cancer 
Heartburn 
Other condition 
33 
47 
28 
12 
51 
27 
56 
87 
11 
15 
9 
4 
17 
9 
18 
28 
* of whom 80 described themselves as moderate and 7 as heavy drinkers 
 
  
Table 2 Domain and subscale median scores (n-280) 
 Median Inter-quartile range 
Generic Quality of Life# 70 39 
Negative feelings# 
Positive feelings* 
Cognitive problems# 
Sexual problems# 
Physical pain# 
Fatigue# 
Social avoidance# 
10 
22 
9 
10 
8 
13 
8 
7 
10 
6 
11 
7 
9 
8 
Cancer-Specific Quality of 
Life# 
34 25 
Appearance concerns# 
Financial problems# 
Distress over recurrence# 
Family-related distress# 
Benefits of cancer* 
6 
5 
12 
7 
18 
7 
6 
9 
8 
10 
#higher scores indicate poorer quality of life 
*higher scores indicate better quality of life 
 
Table 3 Demographic, lifestyle and clinical factors and their association with cancer-specific 
and generic quality of life scores. 
 Mean Cancer-Specific 
QoL Score# (sd) 
P Mean Generic 
QoL Score# (sd) 
p 
Gender 
- Male 
- Female 
 
36.21 (16.80) 
42.62 (18.97) 
 
0.009 
 
73.32 (30.24) 
83.81 (33.52) 
 
0.018 
Age 
- <45 years 
- 45 – 54 years 
- 55 – 64 years 
- 65 – 74 years 
- ≥75 years  
 
43.81 (21.07) 
46.84 (19.98) 
40.54 (18.68) 
34.07 (13.87) 
31.46 (15.51) 
 
<0.001 
 
83.77 (31.19) 
82.94 (38.27) 
79.79 (35.59) 
69.98 (26.83) 
73.32 (22.16) 
 
0.118 
SIMD 
- 1 (most deprived) 
- 2 
- 3 
- 4 
- 5 (least deprived) 
 
44.03 (22.16) 
41.88 (18.57) 
34.65 (13.52) 
36.28 (16.54) 
31.93 (13.91) 
 
0.003 
 
87.47 (39.39) 
81.86 (31.60) 
73.22 (29.93) 
72.13 (28.98) 
65.93 (22.56) 
 
0.008 
Living arrangements 
- Another 
person lives in 
household 
- Lives alone 
 
37.77 (17.28) 
 
 
37.63 (17.99) 
 
0.954 
 
75.86 (30.83) 
 
 
76.50 (33.71) 
 
0.895 
Smoking status 
- Non-smoker 
- Smoker 
 
36.03 (16.47) 
45.40 (20.22) 
 
0.003 
 
73.59 (28.52) 
86.98 (40.58) 
 
0.036 
Alcohol status 
- Non-drinker 
- Drinker 
 
39.70 (19.02) 
36.75 (16.71) 
 
0.211 
 
82.20 (33.26) 
72.55 (29.85) 
 
0.017 
Employment status 
- Out of work 
- Employed 
- Retired 
 
44.48 (20.26) 
38.76 (16.75) 
32.16 (14.20) 
 
<0.001 
 
87.97 (37.76) 
70.61 (26.43) 
71.61 (27.66) 
 
<0.001 
Diagnosis 
- Larynx 
- Oropharynx 
- Oral cavity 
- Other 
 
33.69 (17.25) 
36.85 (14.65) 
42.56 (17.66) 
38.01 (20.19) 
 
0.010 
 
73.14 (29.64) 
73.17 (29.73) 
80.84 (32.72) 
76.88 (34.13) 
 
0.357 
Length of time since 
diagnosis 
- Up to 1 year 
- 1-2 years 
 
 
35.10 (16.08) 
36.77 (14.46) 
 
 
0.795 
 
 
73.82 (30.39) 
73.61 (32.39) 
 
 
0.980 
- 2-3 years 
- 3-4 years 
- >4 years 
39.95 (19.51) 
38.47 (17.26) 
36.68 (18.94) 
75.88 (27.88) 
76.29 (27.12) 
77.04 (37.20) 
Type of treatment 
- Surgery alone 
- Other 
treatment~ 
 
38.26 (18.08) 
 
37.56 (17.29) 
 
0.773 
 
79.64 (33.82) 
 
74.47 (30.43) 
 
0.243 
Feeding tube fitted 
- Never 
- Ever 
 
32.39 (14.73) 
41.93 (18.53) 
 
<0.001 
 
71.16 (25.71) 
79.92 (35.00) 
 
0.022 
~ Treatment including chemotherapy or radiotherapy  
# higher scores indicate poorer quality of life 
 
Table 4 Summary of hierarchical regression analysis for variables predicting cancer-specific and generic quality of life 
 Cancer-specific quality of life  Generic quality of life 
 Model 1 Model 2 Model 3  Model 1 Model 2 Model 3 
 (Demographics) (Demographics 
+ Lifestyle) 
(Demographics, 
Lifestyle 
+Clinical) 
 (Demographics) (Demographics 
+ Lifestyle) 
(Demographics, 
Lifestyle 
+Clinical) 
Variable β β Β  β β Β 
Female 0.148* 0.131* 0.090  0.142* 0.106 0.098 
Age -0.280** -0.264** -0.292**  -0.158* -0.153* -0.213** 
Living alone 0.030 0.031 0.000  0.009 0.017 0.003 
SIMD -0.213** -0.152* -0.168**  -0.221** -0.150* -0.145* 
Current smoker  0.114 0.095   0.128* 0.074 
Current non-drinker  -0.068 -0.028   -0.135* -0.074 
Not employed or retired  -0.224** -0.144*   -0.227** -0.150* 
Time since diagnosis   0.030    -0.016 
Number of comorbidities   0.243**    0.389** 
Treatment other than surgery 
alone 
  0.090    -0.003 
Feeding tube ever fitted   0.204**    0.112 
Oropharynx diagnosis   -0.047    -0.039 
Oral cavity diagnosis   0.172*    0.034 
Other site diagnosis   0.061    0.030 
ΔR2 0.147** 0.068** 0.122**  0.098** 0.083** 0.147** 
Total R2 0.147** 0.215** 0.337**  0.098** 0.181** 0.328** 
*p<0.05 
**p<0.01 
Table 5 Cancer-specific quality of life subscale median scores for feeding tube and type of diagnosis 
 Appearance 
concerns 
p Financial 
problems 
p Distress over 
recurrence 
p Family related 
distress 
p Benefits of 
cancer 
p 
Feeding Tube  
Median (IQR) 
Ever Fitted 
Never Fitted 
 
 
9 (11) 
4 (3) 
 
 
<0.001 
 
 
7.5 (8) 
4 (4) 
 
 
<0.001 
 
 
12 (10) 
11 (9) 
 
 
0.069 
 
 
7.33 (9) 
5.33 (8) 
 
 
0.044 
 
 
18 (10) 
16.5 (10) 
 
 
0.524 
Type of Diagnosis 
Median (IQR) 
Larynx 
Oropharynx 
Oral Cavity 
Other 
 
 
4 (5) 
6 (6) 
8 (9) 
5 (10) 
 
 
0.009 
 
 
4 (5) 
8 (9) 
6 (7) 
4 (4) 
 
 
0.073 
 
 
10 (9) 
11 (8) 
15 (10) 
12 (11) 
 
 
0.001 
 
 
5.33 (7) 
7.33 (8) 
8.66 (9) 
6 (9) 
 
 
0.105 
 
 
18 (10) 
18 (13) 
18 (8) 
16 (12) 
 
 
0.631 
 
  
Table 6 QLACS sub-scale median scores by SIMD category 
 SIMD 1 SIMD 2 SIMD 3 SIMD 4 SIMD 5 p 
Generic Quality of Life Median (IQR) Median (IQR) Median (IQR) Median (IQR) Median (IQR)  
Negative feelings# 
Positive feelings* 
Cognitive problems# 
Sexual problems# 
Physical pain# 
Fatigue# 
Social avoidance# 
11 (9) 
22 (13) 
11 (12) 
10 (9) 
10 (9) 
16.5 (10) 
10 (11) 
10 (6) 
21 (9) 
9 (5) 
14 (12) 
9 (9) 
12 (9) 
8 (11) 
9 (6) 
22.5 (10) 
9 (6) 
10.5 (12) 
8 (80) 
12 (8) 
7.5 (9) 
9 (5) 
22 (9) 
8 (7) 
10 (11) 
7 (6) 
12 (8) 
7 (7) 
9 (6) 
22 (7) 
7 (6) 
9 (9) 
6 (5) 
12 (6) 
7 (7) 
0.146 
0.370 
0.085 
0.125 
0.004 
0.046 
0.227 
Cancer-Specific Quality of 
Life 
      
Appearance concerns# 
Financial problems# 
Distress over recurrence# 
Family-related distress# 
Benefits of cancer* 
7 (11) 
7 (10) 
15.5 (15) 
7.16 (9) 
17 (10) 
8 (11) 
6 (7) 
14 (11) 
9 (8) 
18 (10) 
6.5 (7) 
4 (4) 
12 (7) 
5.5 (8) 
18 (10) 
5 (6) 
6 (7) 
11 (9) 
6.66 (9) 
18 (11) 
5 (5) 
4 (5) 
10 (6) 
5.33 (6) 
19 (10) 
0.173 
0.067 
0.067 
0.108 
0.477 
*higher scores indicate better quality of life 
#higher scores indicate poorer quality of life 
NB SIMD 1 = most deprived; SIMD 5 = least deprived 
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